All Type of News
Newly modified drugs draw little attention
Despite the fact that Korean drug makers, such as Hanmi and Korea United, launched their chemically modified medicines with better utility and safety profile, their local sales have been still unsatisfactory, accordin...
Wholesalers recognize financial costs by 3%
The Korea Association of Pharmaceutical Wholesaler has recently decided to provide pharmacies with an official rebate in the form of financial costs depending on the money collection period.
Under the plan, wholesa...
Choongwae says avanafil shows efficacy in 15 minutes
Choongwae Pharma announced on July 5 new data from an analysis of the recently completed phase 3 study of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED).
In the study of ...
40 medicines should not be co-prescribed, HIRA says
The Health Insurance Review and Assessment Service said on July 4 that a total of 40 drugs should not be concomitantly used with others, or has safety problems and age limitations.
Administration of atorvastatin 80...
Drugmakers seeking to raise prices of renowned brand items
Some pharmaceutical companies, such as CJ Cheil Jedang, Handok and Janssen Korea, have tried to increase their renowned OTC (over-the-counter) medicines through modification of packages and/or addition of some ingredi...
KPMA lukewarm over unified distribution policy
The Korea Pharmaceutical Manufacturers Association said on July 1 it has not officially support the unified distribution system of pharmaceutical wholesalers.
The association added that the issue should be approved...
6,857 drugs withdrawn from health insurance
The National Health Insurance has excluded a total of 6,857 drugs from the list of 21,740 insured medicines in 2006 and as a result, there are 14,883 medicines that are covered by the Health Insurance as of January th...
KT Commerce extends its MRO service to drugmakers
KT Commerce Corporation, KT Group’s electronic commerce corporation, says it has provided its MRO service for Hyundai Pharm and Ahngook Pharm to help these businesses save on costs on research and development equipmen...
Bioequivalence guideline for capecitabine to boost launch of Xeloda generic drugs
Korean makers of generic drugs are seeking the Korea Food and Drug Administration approval to sell a copy of Xeloda, whose active ingredient is capecitabine.
To this end, the KFDA has recently announced its new bio...
Dong-A Pharm to sell GSK’s Polident denture cleanser in September
Dong-A Pharmaceutical Co. says it will market GlaxoSmithKline (GSK)’s Polident denture cleanser from September, while GSK will be responsible for selling an oral refresher Garglin.
A business division that will joi...
